Key Takeaways
- •Oxytocin is a cyclic nonapeptide, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, closed by a disulfide bridge between cysteines 1 and 6, with CAS 50-56-6, formula C43H66N12O12S2 and an average mass of 1007.2 g/mol.
- •The acetate is a salt of that same peptide, with its own CAS 6233-83-6, formula C45H70N12O14S2 and an average mass of 1067.2 g/mol.
- •The salt form changes the arithmetic by about 5.6%. The peptide accounts for roughly 94.4% of the acetate salt's mass, so a certificate has to say which form was weighed.
- •Oxytocin is prescription-only in Canada, and research-grade oxytocin acetate is not that product. The three marketed human products are hospital obstetric products from Pfizer, Fresenius Kabi and Hikma, and no other formulation and no over-the-counter product is authorized. The research material holds no DIN and is supplied for laboratory use only.
- •ISMP Canada lists oxytocin as a high-alert medication in its use to start or advance labour.
- •The disulfide bridge is the stability liability. Degradation of oxytocin in aqueous solution is well characterized and proceeds through routes a purity figure taken at release will not predict.
Summary
In Canada oxytocin is a prescription-only medicine: every oxytocin product in Health Canada's Drug Product Database carries a prescription schedule, the marketed human products are hospital obstetric products, and no other formulation is authorized. Research-grade oxytocin acetate is a different product, with no DIN and no authorization, supplied for laboratory work only. The acetate salt weighs about 6% more than the free peptide, so a certificate has to say which form its figures describe. The disulfide ring is the stability liability, and confirming it takes mass spectrometry rather than a purity figure.
Can you buy oxytocin in Canada? As a medicine, only on prescription and only as a hospital product: every oxytocin product in Health Canada's Drug Product Database is listed as prescription-only, the three human products currently marketed are all sterile solutions used in obstetric care, and no other oxytocin formulation is authorized here. That makes oxytocin acetate the one compound on a Canadian research shelf whose active ingredient is also a marketed Canadian drug, and the single case where the line between an authorized pharmaceutical and a research material cannot be hand-waved. Both exist, they are not the same product, and they are not even the same salt.
This guide covers what oxytocin is as a molecule, how the acetate differs from the free peptide, exactly what Health Canada has authorized and what it has not, how oxytocin compares with vasopressin and carbetocin, what the research literature measured, and why a nonapeptide with a disulfide bridge needs a different reading of a certificate. It is written for laboratory and in-vitro research procurement. It reports what published studies recorded because that is the public evidence base, and it contains no dosing, administration or human-use guidance, and none should be inferred.
What Oxytocin Is
Oxytocin is a neuropeptide hormone: it is synthesized by neurons of the hypothalamus, released from the posterior pituitary, and also acts as a chemical messenger within the brain.
Oxytocin was the first peptide hormone to be sequenced and synthesized, work for which Vincent du Vigneaud received the 1955 Nobel Prize in Chemistry. Its chemistry has been settled for seventy years, which makes it an unusually good reference point for reading a certificate.
| Property | Value (free peptide) | Value (acetate salt) |
|---|---|---|
| Sequence | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 | same peptide |
| Ring closure | Disulfide, Cys1 to Cys6 | same |
| Residues | 9 | 9 |
| CAS number | 50-56-6 | 6233-83-6 |
| Molecular formula | C43H66N12O12S2 | C45H70N12O14S2 |
| Average mass | 1007.2 g/mol | 1067.2 g/mol |
| Monoisotopic mass | 1006.4365 Da | 1066.4576 Da |
Those values agree with PubChem CID 439302 for the free peptide and CID 12004215 for the acetate.

The molecule has two structural features that matter downstream. It is cyclic, closed by a disulfide between the two cysteines, with a three-residue tail carrying a C-terminal amide. And it contains a glutamine at position 4 and an asparagine at position 5, both of which are amide side chains and both of which are the residues most prone to deamidation in aqueous solution.
The Salt Form Is Not a Labeling Detail
Peptides are supplied as salts, because the free peptide of a basic sequence is difficult to handle and the counterion is a consequence of the purification. "Oxytocin acetate" names the acetate salt of the oxytocin nonapeptide. The peptide inside is identical. What differs is the mass you weigh.
The arithmetic is worth doing once. The free peptide is 1007.2 g/mol and the acetate salt is 1067.2 g/mol, a difference of 60 g/mol, which is the mass of one acetate. So the peptide is about 94.4% of the acetate salt's mass, and 10 mg of the acetate salt contains roughly 9.4 mg of oxytocin peptide if the salt is stoichiometrically clean and dry.
That is the best case and it is rarely the actual case. A real lot also carries water, which a lyophilized peptide takes up readily, and may carry residual solvent or more than one counterion equivalent. The counterion arithmetic is the subject of chain length and counterion, and net peptide content is the measurement that settles it: it reports the fraction of the powder that is peptide, as measured, rather than as computed from an idealized salt.
It also explains an apparent discrepancy a careful buyer will notice across this market, including on Volta's own product page. Suppliers commonly name the product for the salt they ship while quoting the parent peptide's CAS number, formula and mass, because those are the identifiers the peptide is known by. Both numbers are true statements about different things. The useful question is which one the certificate's figures refer to, and a certificate that does not say has left a 5.6% ambiguity in the mass of material you think you bought.
Oxytocin vs Vasopressin and Carbetocin
Oxytocin has two close relatives that matter to anyone reading about it, and both are easy to confuse with it.
| Oxytocin | Vasopressin (arginine) | Carbetocin | |
|---|---|---|---|
| Sequence | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 | Oxytocin analogue with a modified N-terminus and a thioether in place of the disulfide |
| Ring closure | Disulfide, Cys1 to Cys6 | Disulfide, Cys1 to Cys6 | Thioether (carba) bridge |
| Differences from oxytocin | None | Positions 3 (Phe for Ile) and 8 (Arg for Leu) | N-terminal and bridge modifications |
| Authorized in Canada | Yes, prescription hospital product | Yes, prescription | Yes, prescription (Duratocin and a generic carbetocin) |
Vasopressin differs from oxytocin at only two of nine positions, which is why the two hormones cross-react at each other's receptors at high concentrations. Carbetocin is a longer-acting synthetic analogue built to resist the degradation routes described below, and it is marketed in Canada as Duratocin by Ferring and as a generic carbetocin by Juno Pharma Canada.
Can You Buy Oxytocin in Canada?
This is the one table in this series with two columns that disagree, and the disagreement is the point.
| Question | Authorized oxytocin product | Research-grade oxytocin acetate |
|---|---|---|
| Drug Identification Number | Yes, multiple | None |
| Authorized as a medicine in Canada | Yes | No |
| Currently marketed in Canada | Yes | Not applicable |
| Lawfully sold as a medicine | Yes, as an authorized product | No |
| Prescription required | Yes, every listed product | Not a medicine |
| Authorized form | Sterile solution for hospital obstetric use | None |
| Any other formulation authorized | No | No |
| Supplied as | Prescription drug | Research material, in vitro use only |
An active-ingredient search of the Health Canada Drug Product Database for oxytocin returns nineteen drug codes. Of those, several are recorded as currently marketed, including products from Pfizer Canada ULC (DIN 00497398), Fresenius Kabi Canada Ltd (DIN 02139561) and Hikma Canada Limited (DIN 02550199). The list also contains veterinary products, and a number of entries in dormant or cancelled states, which is normal for an ingredient with a long market history. Every one of the nineteen entries, human and veterinary, carries a prescription schedule, and every human product is a sterile solution for hospital use.
That answers the three questions Canadians most often ask about it. Oxytocin is not available over the counter. It cannot be bought legally without a prescription, because there is no non-prescription product. And the other oxytocin formulations advertised online are not authorized products in Canada: no such formulation appears in the database at all. ISMP Canada, the national medication-safety organisation, classifies oxytocin as a high-alert medication in its use to start or advance labour.
None of that authorization attaches to research-grade material. An authorized drug product is a specific formulation, made to a specific standard, in a specific presentation, by a named manufacturer, against a submission Health Canada reviewed. Research-grade oxytocin acetate is a lyophilized powder of the same peptide in a different salt form, with no marketing authorization, no DIN and no assessment of safety, efficacy or quality by any regulator. The shared active ingredient does not transfer the authorization, and the existence of an approved oxytocin product in Canada is not a statement about any research material.
That distinction is sharper here than anywhere else in this series, because for every other compound covered the answer is simply that nothing is authorized. The general framework for research material, and why a research-use label does not make a product lawful for human use, is in are peptides legal in Canada.

What the Published Research Measured
Oxytocin has an enormous literature spanning peripheral physiology and central nervous system work, and the two halves are often conflated in supplier copy.
The classical work concerns the peptide's actions on smooth muscle, which is the basis of the authorized clinical products. The newer and larger body of work concerns central effects, and its central methodological problem is delivery: the peptide crosses the blood-brain barrier poorly, so separating central from peripheral effects is difficult and the delivery method shapes what a study can conclude. Recent examples illustrate how carefully those studies are framed: a 2026 trial in Diabetes, Obesity and Metabolism reported that oxytocin did not affect glucose-regulating hormones or bone turnover markers during graded glucose infusion in healthy men (PMID 42687772), and a 2026 review in Translational Psychiatry examines the translational pathways of oxytocin in schizophrenia and the gap between neural mechanism and symptom domains (PMID 42236472).
The literature most useful to a buyer, though, is the stability work, because it is about the material rather than the biology:
- A 2013 paper in Biopolymers addresses the mechanism of degradation of oxytocin and its analogues in aqueous solution (PMID 23868209).
- A 2013 paper in the International Journal of Pharmaceutics reports that aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation (PMID 23376504).
- Later work examines excipients and conjugation approaches intended to stabilize it, including crown ethers (PMID 33681619), sugars and glycols (PMID 34620274) and N-terminal PEGylation (PMID 27419537).
A compound with that many stabilization papers written about it is a compound that degrades readily in solution. That is the single most useful thing to know about handling it, and it is part of the reason carbetocin, with its more stable thioether bridge, was developed.
How to Verify an Oxytocin Acetate Lot
Establish which form the figures describe. Ask whether the reported mass and the net peptide content refer to the free peptide or the acetate salt. The gap is about 5.6% before water is counted, and it propagates into every concentration calculated from the vial.
Net peptide content is not optional here. Because the material is supplied as a salt and takes up water, the fraction of the powder that is peptide is the figure that determines what you actually weighed out. A purity ratio does not answer it.
Ask how the disulfide was confirmed. The molecule is cyclic, and the linear reduced form has the same amino acid composition and nearly the same mass, differing by about 2 Da for the two hydrogens. A mass spectrometric method with adequate resolution distinguishes them, as what actually proves a peptide sequence explains; a chromatographic purity figure may not, and the reduced form is a different molecule with different behavior. Dimerization through the disulfide is a known degradation route, and a dimer is a mass spectrometry finding rather than a purity finding. The Canadian checklist is in how to verify a peptide in Canada.
Treat release data as a release measurement. The stability literature above concerns aqueous solution, so a figure measured at release on a lyophilized powder does not describe the material after reconstitution. Storage conditions on the vial are load-bearing for this compound in a way they are not for a proline-rich linear peptide.
Check the three things that make a certificate checkable:
- The laboratory is named, with its report number.
- The lot number on the document matches the vial in your hand.
- The laboratory publishes a verification page where the report number can be looked up independently.
A certificate that names no laboratory, or whose lot number matches nothing on the container, is a document about some other material. Volta publishes its certificates as page images in its published certificate archive with the issuing laboratory's own verification link, and a certificate for the batch you receive is available on request. Those reports carry both HPLC and mass spectrometry results.
Frequently Asked Questions
What is oxytocin acetate?
It is the acetate salt of oxytocin, a cyclic nine-residue peptide with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 closed by a disulfide bridge between cysteines 1 and 6. The acetate salt has CAS 6233-83-6, formula C45H70N12O14S2 and an average mass of 1067.2 g/mol; the free peptide is CAS 50-56-6 at 1007.2 g/mol.
Can I buy oxytocin in Canada?
Only as a prescription medicine. Every oxytocin product in Health Canada's Drug Product Database is prescription-only, and the three marketed human products are hospital products from Pfizer, Fresenius Kabi and Hikma used in obstetric care. Research-grade oxytocin acetate is not a medicine and is supplied for laboratory use only.
Is oxytocin available over the counter in Canada?
No. There is no non-prescription oxytocin product in Canada; every listed product carries a prescription schedule.
Is any other oxytocin formulation authorized in Canada?
No. The Drug Product Database lists only hospital oxytocin products, so any other formulation sold online has no Canadian authorization.
What is the difference between oxytocin and carbetocin?
Carbetocin is a longer-acting synthetic analogue of oxytocin in which the disulfide bridge is replaced by a more stable thioether. It is a separately authorized prescription product in Canada, marketed as Duratocin and as a generic carbetocin.
Is oxytocin legal in Canada?
Oxytocin is an authorized prescription drug in Canada, with live Drug Identification Numbers from Pfizer, Fresenius Kabi and Hikma among others. Research-grade oxytocin acetate is a different product with no marketing authorization and no DIN, and is supplied for laboratory use only, a position set out in what that means in Canadian law. The authorization of the pharmaceutical product does not extend to research material.
Is research-grade oxytocin acetate the same as the authorized product?
No. The peptide is the same, but the salt form differs, and an authorized drug product is a specific formulation made to a specific standard by a named manufacturer against a reviewed submission. A lyophilized research powder is none of those things, whatever the active ingredient.
How much peptide is in 10 mg of the acetate salt?
Roughly 9.4 mg, if the salt is stoichiometrically clean and dry, because the peptide is about 94.4% of the acetate's formula mass. A real lot also carries water and possibly residual solvent, which is why net peptide content is measured rather than calculated.
Why does the disulfide bridge matter for verification?
The cyclic molecule and its reduced linear form share an amino acid composition and differ by about 2 Da, and dimerization through the disulfide is a known degradation route. Distinguishing these needs mass spectrometry with adequate resolution; a purity percentage may not separate them.
Does oxytocin degrade in solution?
Yes, readily, which is why the literature contains a substantial body of work on stabilizing it, including studies of buffers, divalent metal ions, crown ethers, sugars and PEGylation. A purity figure measured at release on a lyophilized powder does not describe the reconstituted material.
Sources
- Health Canada Drug Product Database, active-ingredient search for oxytocin: nineteen drug codes, all on a prescription schedule, including currently marketed human products from Pfizer Canada ULC (DIN 00497398), Fresenius Kabi Canada Ltd (DIN 02139561) and Hikma Canada Limited (DIN 02550199); checked 10 November 2026.
- Health Canada Drug Product Database, active-ingredient search for carbetocin: DURATOCIN (Ferring Inc., DIN 02496526) and a generic carbetocin (Juno Pharma Canada Inc., DIN 02489244), both marketed, prescription; checked 10 November 2026.
- ISMP Canada. "Oxytocin to Start or Advance Labour: 5 Questions to Ask." Identifies oxytocin as a high-alert medication.
- PubChem Compound Summary, CID 439302 (Oxytocin) and CID 12004215 (Oxytocin acetate). National Library of Medicine. Sequence, formulas, average masses and monoisotopic masses as cited above.
- Biopolymers. 2013. "On the mechanism of degradation of oxytocin and its analogues in aqueous solution." PMID 23868209.
- International Journal of Pharmaceutics. 2013. "Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation." PMID 23376504.
- ACS Omega. 2021. "Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions." PMID 33681619.
- Die Pharmazie. 2021. "The effect of D-(+)-glucosamine, N-acetyl-D-glucosamine and tetraethylene glycol on the stability of oxytocin in aqueous solution." PMID 34620274.
- Biomacromolecules. 2016. "Stability Enhancing N-Terminal PEGylation of Oxytocin Exploiting Different Polymer Architectures and Conjugation Approaches." PMID 27419537.
- Diabetes, Obesity and Metabolism. 2026. "Intravenous Oxytocin Does Not Affect Glucose-Regulating Hormones or Markers of Bone Turnover During Graded Glucose Infusion in Healthy Men." PMID 42687772.
- Translational Psychiatry. 2026. "Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms." PMID 42236472.

